[Susceptibility to fluconazole of clinical interest yeasts: new breakpoints]

Lidia García-Agudo1, Pedro García-Martos, Pilar Marín-Casanova

  • 1Servicio de Microbiología y Parasitología, Hospital Universitario Puerta del Mar, Spain.

Abstract

Insights

New fluconazole susceptibility breakpoints from Pfaller et al. show decreased susceptibility in Candida species, particularly Candida albicans, compared to Clinical and Laboratory Standards Institute (CLSI) criteria. This impacts antifungal resistance monitoring.

Area of Science:

  • Medical Mycology
  • Antimicrobial Susceptibility Testing
  • Infectious Diseases

Background:

  • Proposed new breakpoints for fluconazole susceptibility testing by Pfaller et al. for Candida albicans, C. parapsilosis, and C. tropicalis.
  • Comparison with existing breakpoints from the Clinical and Laboratory Standards Institute (CLSI) is needed.

Purpose of the Study:

  • To evaluate variations in Candida species' sensitivity to fluconazole using new proposed breakpoints.
  • To compare these variations against established CLSI breakpoints.

Main Methods:

  • Analysis of 112 Candida strains (49 C. albicans, 40 C. parapsilosis, 23 C. tropicalis).
  • Fluconazole susceptibility testing using the Sensititre YeastOne method.
  • Determination of minimum inhibitory concentrations (MICs) using both CLSI and Pfaller et al. breakpoints.

Main Results:

  • Under CLSI criteria, all isolates were susceptible to fluconazole.
  • Using Pfaller et al. criteria, 97% of strains remained susceptible, with 3 C. albicans strains (6%) showing dose-dependent susceptibility.
  • A decrease in the number of fluconazole-susceptible strains was observed with the new breakpoints, especially for C. albicans.

Conclusions:

  • The new breakpoints recommended by Pfaller et al. and EUCAST lead to a reduction in fluconazole-susceptible Candida strains compared to CLSI criteria.
  • This highlights the clinical significance of updated breakpoints for accurate antifungal susceptibility interpretation.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...